Sazan Anwar is a Stockholm-based Associate and a member of Roschier’s Public M&A, Equity Capital Markets and Corporate Advisory practices. She joined Roschier in 2023.
Sazan Anwar’s experience includes advising:
- Frazier Life Sciences in its investment in Egetis Therapeutics.
Örebro University, LL.M. (2023)
Swedish, English, Kurdish, Turkish